|
May 7
|
Knight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City
|
|
Mar 28
|
Knight Therapeutics Inc. ranks on The Globe and Mail’s fifth-annual Women Lead Here benchmark of executive gender diversity
|
|
Mar 24
|
Knight Therapeutics Inc. Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts
|
|
Dec 19
|
Knight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree® (viloxazine) in Canada
|
|
Nov 9
|
Knight Therapeutics Reports Third Quarter 2023 Results
|
|
Aug 10
|
Knight Therapeutics Reports Second Quarter 2023 Results
|